Developed by scientists in collaboration with the University of Oxford and the National Institutes of Health
Developed through a collaboration between the University of Oxford and the National Institutes of Health with funding from DARPA’s “Metabolic Dominance” program.The groundbreaking research conducted by Dr. Kieran Clarke and Dr. Richard Veech dating back to 2000 has led to the creation of the Oxford Ketone Ester, deltaG®.